Clinical trials
Phase 2 Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
134 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 9 |
| 2021 | 3 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 10 |
| 2025 | 13 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Recruiting | 19 |
| Terminated | 17 |
| Active, not recruiting | 12 |
| Withdrawn | 8 |
| Not yet recruiting | 7 |
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 6 |
| Hoffmann-La Roche | 5 |
| Novartis Pharmaceuticals | 4 |
| Pliant Therapeutics, Inc. | 4 |
| Actelion | 3 |
| Biogen | 3 |
| Haisco Pharmaceutical Group Co., Ltd. | 3 |
| University of Alabama at Birmingham | 3 |
| Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 134 |
| Pulmonary Fibrosis | 31 |
| Lung Diseases, Interstitial | 16 |
| Fibrosis | 12 |
| Lung Diseases | 7 |
| Cough | 6 |
| Idiopathic Interstitial Pneumonias | 6 |
| Hypertension, Pulmonary | 5 |
| Respiratory Tract Diseases | 5 |
| Pulmonary Arterial Hypertension | 4 |
Trials
Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.
34 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.